Exopolysaccharides from Pseudomonas tolaasii inhibit the growth of Pleurotus ostreatus mycelia

Yanyan Xu; Taimei Yao; Haiyan Yan; Longzuo Xin

doi:10.1515/biol-2022-0601

Artikel Open Access

Exopolysaccharides from Pseudomonas tolaasii inhibit the growth of Pleurotus ostreatus mycelia

Yanyan Xu , Taimei Yao , Haiyan Yan und Longzuo Xin

Veröffentlicht/Copyright: 23. Mai 2023

Veröffentlicht von

Veröffentlichen auch Sie bei De Gruyter Brill

Manuskript einreichen Informationen für Autor*innen Erkunden Sie dieses Fachgebiet

Aus der Zeitschrift Open Life Sciences Band 18 Heft 1

Abstract

In the present study, the effect of exopolysaccharides (EPSs) extracted from Pseudomonas tolaasii on the growth of Pleurotus ostreatus mycelia was determined. P. ostreatus mycelia was cultivated with different concentrations of P. tolaasii EPSs, and their mycelial growth rate, protein content, and enzyme activity were measured and compared. The results showed that EPSs inhibited the growth of P. ostreatus. The proline and vitamin C contents of P. ostreatus increased at an EPS concentration of 40%. The cellulase, α-amylase, protein, and glucose utilisation rates of P. ostreatus gradually decreased with the increase in EPS concentration. Altogether, P. tolaasii EPSs had a significant inhibitory effect on mycelial growth. Therefore, we concluded that in addition to tolaasin, EPSs may also be the virulence factors responsible for the pathogenesis of P. tolaasii.

Keywords: Pseudomonas tolaasii ; exopolysaccharides; Pleurotus ostreatus

1 Introduction

Pseudomonas tolaasii is the causative agent of brown blotch disease (BBD) in Pleurotus ostreatus, Agaricus bisporus, Flammulina velutipes, and Pleurotus eryngii [1]. With the advancements in production methods and large-scale cultivation, the incidence of bacterial BBD continues to increase. BBD is known to affect the yield and quality of edible fungi [2].

BBD can occur at any time during the growth of P. ostreatus fruiting bodies. In P. ostreatus, BBD is caused by the secretion of the extracellular lipodepsipeptide toxin tolaasin by P. tolaasii [3,4] through a non-ribosomal mechanism that binds multiple enzymes [5–9]. In addition, tolaasin synthesis is controlled by gene regulation [10,11]. Extracellular toxins cause yellow-brown spots on the surface of mushrooms, including P. ostreatus, by changing their permeability or directly destroying the cell membrane to form cavities, which affects the transmembrane transport of ions [12,13]. These yellow-brown spots are caused by the infected fruit body in the process of fruit body damage or senescence, when the phenolic substances in the fruit body are oxidised into quinones and aggregated into melanin. Tolaasin is thought to be the main pathogenic cause of BBD in P. ostreatus [12].

Some extracellular factors also affect P. ostreatus mycelia, assisting the invasion of P. ostreatus mycelium by P. tolaasii. Aminobenzene [14], Tolaasin II [15], methanethiol, dimethyl disulphide, and 1-undecene [16] are factors potentially involved in the development of BBD symptoms.

The aim of the present study was to provide a theoretical basis for further studies on the pathogenic mechanism of P. tolaasii as well as to lay a foundation for the prevention and control of BBD in P. ostreatus. Exopolysaccharides (EPSs) were extracted from the extracellular fluid of P. tolaasii. P. ostreatus mycelia were cultivated with different EPS concentrations in a solution to determine their growth rate; intracellular proline and vitamin contents; amounts of extracellular carboxymethyl cellulose (CMC) enzymes, α-amylase, and laccase; glucose utilisation rate; and protein content. Various virulence factors were used to elucidate the pathogenic mechanisms of P. tolaasii.

2 Materials and methods

2.1 Bacterial strains and culture conditions

A single colony of P. tolaasii (CGMCC 1.19361) was inoculated in the Luria–Bertani (LB) liquid medium and incubated at 30°C with shaking it for 48 h.

2.2 Extraction of P. tolaasii EPSs

The cultivated bacterial liquid was placed in a 100°C water bath for 10 min to inactivate the enzymes. The bacterial solution was centrifuged for 15 min at 4°C and 8,000 rpm. The supernatant was collected after centrifugation, 12% trichloroacetic acid solution of half the volume of the supernatant was added, and the proteins were removed from the supernatant after stirring for 30 min. Following centrifugation at 4°C at 8,000 rpm for 15 min (Sigma 3-18KS, Harzberg am Harz, Germany), the supernatant was collected, mixed with 2–3 times its volumes of 95% ethanol solution, and precipitated overnight. Then, the solution was centrifuged at 4°C and 8,000 rpm for 15 min to obtain a precipitate containing EPSs, after which it was weighed [11,17].

Based on the quality of the EPSs, the precipitate was diluted with sterile water to prepare EPS solutions with different concentrations. After preparation, the bacteria were removed using a 0.22 µm filter (Millipore, MA, USA) and used as a backup (Table 1).

Table 1

Preparation of different EPS concentrations

Concentration (g/mL)	EPS (g)	Sterile water (mL)
3%	0.3	10
5%	0.5	10
10%	2	20
20%	2	10
30%	3	10
40%	4	10

2.3 Growth rate of mycelia with EPSs

P. ostreatus was inoculated on a potato dextrose agar (PDA) plate and incubated at 25°C until the plate was covered. Then, 100 μL of the solutions with different EPS concentrations (0, 3, 5, 10, 20, 30, or 40%) was added to the PDA plate. Sterile water was used as the control. Plate-grown P. ostreatus was perforated with a perforator (1 cm diameter), inoculated on the PDA with an inoculum tweezer (three replicates per concentration), and incubated at 25°C. Mycelial growth was measured by the cross–cross method and averaged from day 2 [18]. Mycelial growth was determined using the following formula: Growth rate of mycelium = Colony diameter (mm)/day.

2.4 Intracellular crude extraction from P. ostreatus mycelia

P. ostreatus was inoculated into the PDA media containing different EPS concentrations and incubated at 25°C. The mycelia were collected at 10 dpi, grinded with liquid nitrogen and mixed with ten times volume of distilled water, and then centrifuged at 4°C and 4,000 rpm for 10 min. The supernatant was collected as a crude extraction solution.

2.5 Measurement of proline and vitamin C content in P. ostreatus mycelia

A standard proline solution (100 μg/mL) was prepared and diluted to the desired concentration. Optical density (OD) was measured at a wavelength of 520 nm (Liuyi, Beijing, China) using the ninhydrin colorimetric method. Using proline content as the abscissa, the density value was plotted on the ordinate as a standard curve. The proline content was determined according to method 979.20 of the Association of Official Analytical Chemists [1]. The results are expressed as μg proline/1,000 g mycelium. The vitamin C content of the mycelia was determined using a spectrophotometric procedure (Liuyi), as described by Bajaj and Kaur [19].

2.6 Extraction of extracellular crude enzymes of P. ostreatus mycelia

The P. ostreatus strain cultured on the PDA plate was peeled off and placed in prepared liquid tubes at different EPS concentrations (0, 10, 30, and 40%). The culture medium was shaken at 25°C and the liquid medium was prepared as shown in Table 2. After culturing for 3 days, the liquid medium was centrifuged at 4°C and 4,000 rpm for 15 min, and the supernatant was collected as an extracellular crude enzyme solution.

Table 2

Preparation of different EPS concentrations in liquid medium

Treatment (%)	EPS (g)	Sterile water (mL)	PD (mL)
10	1	9	1
30	3	9	1
40	4	9	1

2.7 Extracellular enzyme activity of P. ostreatus mycelia

2.7.1 Carboxymethyl cellulase (CMCase) activity

The CMCase activity of the mycelia was determined using CMC (Sigma-Aldrich Corporation, St Louis, MO, USA) [20]. CMCase (EC 3.2.1.4) hydrolyses the β-1.4 glucosidic linkage in the carboxyl cellulose molecule and releases the reducing sugar (glucose), which reacts with 3,5-dinitrosalicylic acid (DNS) [21] and produces a colour change proportional to the amount of released reducing sugar (glucose), which is proportional to the enzyme activity in the sample. The amount of reducing sugar produced was determined by measuring the absorbance at 540 nm (using glucose as a standard) (Liuyi) to measure the extent of enzyme activity.

2.7.2 α-Amylase activity

The α-amylase activity of the extracellular crude enzyme solution was measured using the 3,5-DNS method [22]. The OD of the samples was measured at a wavelength of 590 nm (Liuyi) [23]. The results are expressed as U/L.

2.7.3 Laccase activity

Laccase activity of the extracellular crude enzyme solution was determined using 2,6-dimethoxyphenol as a substrate, as described previously [10]. The OD was recorded at a wavelength of 468 nm (Liuyi) [24]. The amount of enzyme required to oxidise 1 μmol of substrate per minute was defined as 1 U enzyme activity.

2.8 Extracellular protein and glucose utilisation rate of P. ostreatus mycelia

After centrifugation, the crude enzyme solution was assayed for protein content using the Coomassie Brilliant Blue Kit A054-2 in accordance with the manufacturer’s instructions (Nanjing Jiancheng Bioengineering Institute, Nanjing, China). The extracellular sugar content was determined using a biosensor (Institute of Biology, Shandong Academy of Sciences, Jinan, China). After calibration of the standard product, the concentration of a 25 μL sample aliquot was determined and recorded.

2.9 Data analysis

All experiments were performed in triplicates. The data were analysed using analysis of variance and multiple comparison tests using Excel (Microsoft Corp., Redmond, WA, USA) and the SPSS software (PSS, Inc., Chicago, IL, USA). The confidence level was set at 95% (p ≤ 0.05). The results are presented as mean ± standard deviation (SD).

3 Results

3.1 Effect of P. tolaasii EPSs on the growth rate of P. ostreatus

The growth rates differed significantly under different EPS concentrations (Table 3). The hyphae growth rate of P. ostreatus decreased with the increase of EPS concentration. The negative control of P. ostreatus mycelia had a maximum growth rate of 18 mm/day, whereas the lowest growth rate of 14.2 mm/day was recorded under the 40% EPS concentration treatment. On the plate with EPS, the hyphae were sparse and the colour turned yellow (Figure 1). Based on these findings, we concluded that the EPS of P. tolaasii significantly inhibited the growth of P. ostreatus hyphae.

Table 3

Growth rate of P. ostreatus mycelium at different EPS concentrations

EPS concentration (g/mL)	Growth rate (mm ± SD/day)
0%	18.0 ± 0.000^a
3%	16.5 ± 0.212^b
5%	16.2 ± 0.261b^c
10%	15.9 ± 0.216^c
20%	15.0 ± 0.151^d
30%	14.3 ± 0.262^e
40%	14.2 ± 0.254^e

Note: The lowercase superscript letter in the same column indicates a significant difference at 5% level.

Figure 1

Growth of P. ostreatus mycelium at different EPS concentrations: (a) control, (b) 3% EPS solution, (c) 5% EPS solution, (d) 10% EPS solution, (e) 20% EPS solution, (f) 30% EPS solution, and (g) 40% EPS solution.

3.2 Effect of P. tolaasii EPSs on physiological indices of P. ostreatus

Significant differences were observed in the proline and vitamin C contents of P. ostreatus at different EPS concentrations (Table 4). The contents increased with increasing EPS concentration: the lowest proline and vitamin C contents were recorded in the negative control (14.1 and 0.11 μg/g, respectively) and the highest were recorded at the EPS concentration of 40% (62.4 and 0.69 μg/g, respectively). Therefore, EPSs stimulate P. ostreatus to produce large amounts of proline and vitamin C.

Table 4

Effect of P. tolaasii EPSs on the intracellular physiological indices of P. ostreatus

EPS concentration (g/mL)	Proline content (μg/g) (±SD)	Vitamin C content (μg/g) (±SD)
0%	14.1 ± 0.152^d	0.11 ± 0.011^g
3%	15.3 ± 0.184^c,d	0.25 ± 0.024^f
5%	16.3 ± 0.193^c,d	0.33 ± 0.014^e
10%	17.6 ± 0.121^c,d	0.40 ± 0.072^d
20%	28.9 ± 0.661^c	0.47 ± 0.053^c
30%	39.6 ± 0.925^b	0.59 ± 0.011^b
40%	62.4 ± 0.514^a	0.69 ± 0.041^a

Note: The lowercase superscript letter in the same column indicates a significant difference at 5% level.

The activities of extracellular CMCase, α-amylase, and laccase and contents of proteins and sugars in P. ostreatus were significantly different at different ESP concentrations (Table 5). As the EPS concentration increased, the number of extracellular indicators decreased. The highest CMC enzyme activity was recorded in the negative control (54.6 U/L), whereas the lowest was recorded at an EPS concentration of 40% (20.4 U/L). The highest activity of α-amylase was recorded (37.8 U/L) in the negative control, and the lowest was recorded at an EPS concentration of 40% (18.9 U/L). The highest laccase activity was recorded in the negative control (74.7 U/L) and the lowest enzyme activity was at an EPS concentration of 40% (27.1 U/L). The highest protein content was 1.1 g/L in the negative control, and the lowest content was recorded at an EPS concentration of 40% (0.2 g/L). The lowest glucose utilisation rate in the medium was measured at an EPS concentration of 40% (0.6 g/L) and the highest in the negative control (23.7 g/L).

Table 5

Effect of P. tolaasii EPSs on physiological indices of P. ostreatus

EPS concentration (g/mL)	CMCase (U/L) (±SD)	α-Amylase (U/L) (±SD)	Laccase (U/L) (±SD)	Sugar utilisation rate (g/L) (±SD)	Protein content (gprot/L) (±SD)
0%	54.6 ± 0.011^a	37.8 ± 0.630^a	74.7 ± 0.001^a	23.7 ± 0.101^a	1.1 ± 0.100^a
10%	41.3 ± 1.642^b	29.9 ± 0.891^b	53.8 ± 0.001^b	20.9 ± 0.008^a	0.6 ± 0.044^b
30%	31.4 ± 1.051^c	23.4 ± 0.678^c	32.2 ± 0.003^c	3.1 ± 0.058^b	0.3 ± 0.037^c
40%	20.4 ± 1.200^d	18.9 ± 0.196^d	27.1 ± 0.001^d	0.6 ± 0.142^c	0.2 ± 0.039^c

Note: The lowercase superscript letter in the same column indicates a significant difference at 5% level. The sugar content in the control medium was 3.8 g/L.

4 Discussion

P. tolaasii is the cause of BBD in A. bisporus and P. ostreatus [25]. A toxin produced by P. tolaasii was identified as a lipodepsipeptide that forms an ion channel [26]. This toxin was named tolaasin, and seven of its analogues have been identified [25]. In addition to tolaasins, other toxic substances in P. tolaasii have been reported. In 1994, a compound from a P. tolaasii strain, characterised as an aminobenzene containing an amylamine group, was found to induce symptoms of the disease on the cap of A. bisporus [27]. Furthermore, in 1996, volatile organic compounds called tovsins were found in P. tolaasii; these compounds were found to be different from tolaasins and could induce changes in P. ostreatus and F. velutipes basidiomes [28]. The study in 2015 showed that P. tolaasii can produce volatile substances which induce in vitro mycelial growth inhibition of P. ostreatus and P. eryngii, and A. bisporus and P. ostreatus basidiome tissue blocked brown discoloration [16]. Therefore, in the present study, we extracted the polysaccharides from P. tolaasii and tested whether they affected the growth of P. ostreatus mycelia.

We found that the EPS of P. tolaasii caused strong physiological changes in P. ostreatus hyphae. Proline and vitamin C are important physiological indicators of an organism’s resistance to infection [29]. Proline is the most water-soluble amino acid and is highly hydrated. Its main function is to regulate the intracellular osmotic pressure by stabilising the cell membrane, which enhances an organism’s resistance. We showed that with the increase in the concentration of extracellular EPSs, the contents of proline and vitamin C increased significantly, indicating that the growth of P. ostreatus mycelia was suppressed by EPSs. Therefore, extensive regulation of proline and vitamin C contents is required to maintain the normal life activities of P. ostreatus mycelia. Moreover, with the increase in EPS concentration, the content of proline and vitamin C in P. ostreatus mycelia gradually increased, indicating that the conditions were becoming increasingly adverse. This finding was consistent with the physiological characteristics of plant stress resistance [29].

Proteins and carbohydrates are the major biological macromolecules responsible for various functions in organisms. CMCase can degrade cellulose to produce glucose and laccase can catalyse a variety of phenolic and non-phenolic compounds and simultaneously reduce oxygen to water [30]. α-Amylase (EC 3.2.1.1) catalyses the hydrolysis of α-1,4-glucosidic bonds in starch and related α-glucans [31]. In the present study, P. tolaasii EPS toxin caused a decrease in laccase, α-amylase, and cellulase activities of P. ostreatus, which also affected mycelial growth. The increase in EPS concentration decreased the protein content and enzyme activity, indicating that the structure and function of P. ostreatus mycelia were affected during growth, thereby inhibiting the normal growth of the hyphae.

The virulence factors of the lipopolysaccharides obtained from Shigella species include the endotoxic activities of the molecule’s lipid A component and the ability of the polysaccharide chain – the core and the O-antigenic polysaccharide – to provide the bacterium with resistance to host defence mechanisms, such as opsonisation, phagocytosis, and intracellular killing [32]. In mice, a Yersinia pseudotuberculosis O-polysaccharide-deficient derivative showed reduced virulence upon subcutaneous challenge [33]. The EPS of P. tolaasii caused strong physiological changes in P. ostreatus hyphae. EPS may contain lipopolysaccharides and other polysaccharides that affect the growth and physiology of P. ostreatus hyphae. However, the role of polysaccharides as virulence factors has not been elucidated and requires further investigations.

5 Conclusions

Compared to those in the control, the contents of vitamin C and proline at all EPS concentrations showed sustained increasing trends. The protein content and activities of CMCase, α-amylase, and laccase showed a downward trend with increasing EPS concentration. The EPS extracted from P. tolaasii not only reduced the growth rate, extracellular enzyme activity, and protein content of P. ostreatus but also increased its intracellular stress resistance to supplement the pathogenic mechanism of exocytosis in Bacteroides. We concluded that in addition to tolaasin, EPSs may also act as virulence factors in P. tolaasii.

Funding information: This work was supported by grants from the China National Scholarship Fund, Local Cooperation Project Teaching Method Subproject, Chengde Municipal Finance Bureau, and Science and Technology Bureau Project Fund (201608B001), People’s Republic of China. Hebei Kou mushroom Cultivation Technology Innovation Center Project (Ji Ke Ping Han [2020] No. 30).
Author contributions: Conceptualisation, writing – original draft preparation, Yan Yan Xu; review and editing, Tai Mei Yao and Hai Yan Yan; visualisation, Long Zuo Xin. All the authors have read and agreed to the published version of the manuscript.
Conflict of interest: Authors state no conflict of interest.
Data availability statement: The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

References

[1] Chung IY, Kim YK, Cho YH. Common virulence factors for Pseudomonas tolaasii pathogenesis in Agaricus and Arabidopsis. Res Microbiol. 2014;165(2):102–9.10.1016/j.resmic.2013.12.001Suche in Google Scholar PubMed

[2] Paine SG. Studies in bacteriosis, II. A brown blotch disease of cultivated mushrooms. Ann Appl Biol. 1919;5:206–19.10.1111/j.1744-7348.1919.tb05291.xSuche in Google Scholar

[3] Soler-Rivas C, Jolivet S, Arpin N, Olivier JM, Wichers HJ. Biochemical and physiological aspects of brown blotch disease of Agaricus bisporus. FEMS Microbiol Rev. 1999;23:591–614.10.1111/j.1574-6976.1999.tb00415.xSuche in Google Scholar PubMed

[4] Tolaas A. A bacterial disease of cultivated mushrooms. Phytopathology. 1915;5:51–4.Suche in Google Scholar

[5] Cutri SS, Macauley BJ, Roberts WP. Characteristics of pathogenic non-fluorescent (smooth) and nonpathogenic fluorescent (rough) forms of Pseudomonas tolaasii and Pseudomonas gingeri. J Appl Bacteriol. 1984;57:291–8.10.1111/j.1365-2672.1984.tb01393.xSuche in Google Scholar

[6] Grewal SIS, Han B, Johnstone K. Identification and characterization of a locus which regulates multiple functions in Pseudomonas tolaasii, the cause of brown blotch disease of Agaricus bisporus. J Bacteriol. 1995;177:4658–68.10.1128/jb.177.16.4658-4668.1995Suche in Google Scholar PubMed PubMed Central

[7] Cho KH, Wang HS, Kim YK. Temperature-dependent hemolytic activity of membrane pore-forming peptide toxin, tolaasin. J Pept Sci. 2010;16(2):85–90.10.1002/psc.1199Suche in Google Scholar PubMed

[8] Mortishire-Smith RJ, Drake AF, Nutkins JC, Williams DH. Left handed alpha-helix formation by a bacterial peptide. FEBS Lett. 1991;278:244–6.10.1016/0014-5793(91)80126-NSuche in Google Scholar

[9] Rainey PB, Brodey CL, Johnstone K. Biology of Pseudomonas tolaasii, cause of brown blotch disease of the cultivated mushrooms. Adv Plant Pathol. 1992;8:95–117.Suche in Google Scholar

[10] Castanera R, Omarini A, Santoyo F, Pérez G, Pisabarro AG, Ramírez L. Non-additive transcriptional profiles underlie dikaryotic superiority in Pleurotus ostreatus laccase activity. PLoS One. 2013;8:e73282.10.1371/journal.pone.0073282Suche in Google Scholar PubMed PubMed Central

[11] Rainey PB, Brodey CL, Johnstone K. Identification of a gene cluster encoding three high-molecular-weight proteins, which is required for synthesis of tolaasin by the mushroom pathogen Pseudomonas tolaasii. Mol Microbiol. 1993;8(4):643–52.10.1111/j.1365-2958.1993.tb01608.xSuche in Google Scholar PubMed

[12] Lee Y, Woo Y, Lee S, Kang K, Yong Y, Kim JK, et al. Identification of compounds exhibiting inhibitory activity toward the Pseudomonas tolaasii toxin tolaasin I using in silico docking calculations, NMR binding assays, and in vitro hemolytic activity assays. Bioorg Med Chem Lett. 2009;19(15):4321–4.10.1016/j.bmcl.2009.05.068Suche in Google Scholar PubMed

[13] Mu LL, Lee SM, Kim YK. Pore-forming peptide toxins obtained from various Pseudomonas sp. causing brown blotch disease. Biophys J. 2014;106:87a.10.1016/j.bpj.2013.11.556Suche in Google Scholar

[14] Park SJ, Kim YK. Cytotoxicities of various pore-forming toxins obtained from strains of Pseudomonas tolaasii. Biophys J. 2014;106:87–8a.10.1016/j.bpj.2013.11.557Suche in Google Scholar

[15] Steigenberger J, Mergen C, De Roo V, Geudens N, Martins JC, Heerklotz H. The effect of membrane thickness on the membrane permeabilizing activity of the cyclic lipopeptide tolaasin II. Front Mol Biosci. 2022;9:1064742.10.3389/fmolb.2022.1064742Suche in Google Scholar PubMed PubMed Central

[16] Lo Cantore P, Giorgio A. Iacobellis NS. Bioactivity of volatile organic compounds produced by Pseudomonas tolaasii. Front Microbiol. 2015;6:1082.10.3389/fmicb.2015.01082Suche in Google Scholar PubMed PubMed Central

[17] Khalid N, Asgher M, Hussain F, Iqbal J. Exopolysaccharides production from marine Bacillus strains and their antioxidant and bio-flocculant capacities. Arch Microbiol. 2022;204(5):250.10.1007/s00203-022-02851-8Suche in Google Scholar PubMed

[18] Guadarrama-Mendoza PC, del Toro GV, Ramírez-Carrillo R, Robles-Martínez F, Yáñez-Fernández J, Garín-Aguilar ME, et al. Morphology and mycelial growth rate of Pleurotus spp. strains from the Mexican mixtec region. Braz J Microbiol. 2014;45(3):861–72.10.1590/S1517-83822014000300016Suche in Google Scholar PubMed PubMed Central

[19] Bajaj KL, Kaur G. Spectrophotometric determination of L-ascorbic acid in vegetables and fruits. Analyst. 1981;106:117–20.10.1039/an9810600117Suche in Google Scholar PubMed

[20] Wood TM, Bhat KM. Methods for measuring cellulase activities. Met Enzymol. 1988;160:87–112.10.1016/0076-6879(88)60109-1Suche in Google Scholar

[21] Kubicek C. Release of carboxymethyl-cellulase and β-glucosidase from cell walls of Trichoderma reesei. Eur J Appl Microbiol Biotechnol. 1981;13:226–31.10.1007/BF00500103Suche in Google Scholar

[22] Ergun SO, Urek RO. Production of ligninolytic enzymes by solid state fermentation using Pleurotus ostreatus. Ann Agrar Sci. 2017;15:273–7.10.1016/j.aasci.2017.04.003Suche in Google Scholar

[23] González CF, Farina JI, Figueroa LI. A critical assessment of a viscometric assay for measuring Saccharomycopsis fibuligera α-amylase activity on gelatinised cassava starch. Enzyme Microb Technol. 2002;30:169–75.10.1016/S0141-0229(01)00479-3Suche in Google Scholar

[24] Parenti A, Muguerza E, Iroz AR, Omarini A, Conde E, Castanera R, et al. Induction of laccase activity in the white rot fungus Pleurotus ostreatus using water polluted with wheat straw extracts. Bioresour Technol. 2013;133:142–9.10.1016/j.biortech.2013.01.072Suche in Google Scholar PubMed

[25] Bassarello C, Lazzaroni S, Bifulco G, Cantore PL, Iacobellis NS, Riccio R, et al. Tolaasins A–E, five new lipodepsipeptides produced by Pseudomonas tolaasii. J Nat Prod. 2004;67:811–6.10.1021/np0303557Suche in Google Scholar PubMed

[26] Brodey CL, Rainey PB, Tester M, Johnstone K. Bacterial blotch disease of the cultivated mushroom is caused by an ion channel forming lipodepsipeptide toxin. Mol Plant Microb Interact. 1991;4:407–11.10.1094/MPMI-4-407Suche in Google Scholar

[27] Park CJ, Oh SK, Chun UH. Identification of mushroom brown blotch causing agent from Pseudomonas tolaasii culture broth. Agric Chem Biotechnol. 1994;37:392–6.Suche in Google Scholar

[28] Shirata A. Production of volatile components by Pseudomonas tolaasii and their toxic activity. Ann Phytopathol Soc Jpn. 1996;62:185–93.10.3186/jjphytopath.62.185Suche in Google Scholar

[29] Song C, Fan Q, Tang Y, Sun Y, Wang L, Wei M, et al. Overexpression of DfRaf from fragrant woodfern (Dryopteris fragrans) enhances high-temperature tolerance in tobacco (Nicotiana tabacum). Genes (Basel). 2022;13(7):1212.10.3390/genes13071212Suche in Google Scholar PubMed PubMed Central

[30] Li F, Zhu X, Li N, Zhang P, Zhang S, Zhao X, et al. Screening of Lignocellulose-degrading superior mushroom strains and determination of their CMCase and laccase activity. Sci World J. 2014;2014:763108.10.1155/2014/763108Suche in Google Scholar PubMed PubMed Central

[31] Janeček Š, Svensson B, MacGregor EA. α-Amylase: an enzyme specificity found in various families of glycoside hydrolases. Cell Mol Life Sci. 2014;1(7):1149–70.10.1007/s00018-013-1388-zSuche in Google Scholar PubMed

[32] Lindberg AA, Kärnell A, Weintraub A. The lipopolysaccharide of Shigella bacteria as a virulence factor. Rev Infect Dis. 1991;13(4):S279–84.10.1093/clinids/13.Supplement_4.S279Suche in Google Scholar

[33] Knirel YA, Anisimov AP, Kislichkina AA, Kondakova AN, Bystrova OV, Vagaiskaya AS, et al. Lipopolysaccharide of the Yersinia pseudotuberculosis complex. Biomolecules. 2021;11(10):1410.10.3390/biom11101410Suche in Google Scholar PubMed PubMed Central

Received: 2023-02-08

Revised: 2023-03-15

Accepted: 2023-03-26

Published Online: 2023-05-23

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

https://doi.org/10.1515/biol-2022-0601

Schlagwörter für diesen Artikel

Pseudomonas tolaasii; exopolysaccharides; Pleurotus ostreatus

Creative Commons

BY 4.0